Literature DB >> 28549960

Mycotic Pseudoaneurysm of Internal Carotid Artery Secondary to Lemierre's Syndrome, How to Do It.

Filippo Benedetto1, David Barillà2, Narayana Pipitò1, Graziana Derone1, Andrea Cutrupi1, Chiara Barillà1.   

Abstract

We report the case of a patient with internal carotid artery (ICA) mycotic pseudoaneurysm secondary to Lemierre's syndrome, urgently treated. A 75-year-old man presented to E.R. with a left swelling lesion of the neck and complaining left visions lost since that morning, fever, hypotension, and dyspnea. Since 15 days before developing symptoms, he had sore throat and odynophagia treated with a broad coverage of antibiotic therapy for presumed streptococcal pharyngitis. Preoperative computed tomography angiography images revealed a circular lesion, involving the common carotid artery, carotid bulb, and the proximal part of the internal and external carotid arteries. A pseudoaneurysm of the ICA was detected, and the jugular vein was compressed. A Cormier carotid vein graft bypass was performed. Lemierre's syndrome is a rare syndrome, but it is rarer the carotid artery pseudoaneurysm secondary to Lemierre's syndrome. Surgical treatment is safe and durable in patients with severe infection involving the neck.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28549960     DOI: 10.1016/j.avsg.2017.05.026

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  2 in total

1.  Mycotic internal carotid artery pseudoaneurysm secondary to Mycobacterium tuberculosis.

Authors:  Dennis H Lui; Shreena Patel; Ruhaid Khurram; Michael Joffe; Jason Constantinou; Daryl Baker
Journal:  J Vasc Surg Cases Innov Tech       Date:  2022-03-09

2.  Lemierre syndrome associated mycotic cavernous sinus thrombosis and carotid aneurysm after COVID-19.

Authors:  Yi Ling Dai; Vicki M Chen; Thomas R Hedges; Adel Malek
Journal:  Am J Ophthalmol Case Rep       Date:  2022-06-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.